NephroDI Therapeutics

Philadelphia, United States

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

$2.0M raised

Jun 2024

Venture - Series Unknown

Biopharma Biotechnology Health Care Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NephroDI Therapeutics

How much funding has NephroDI Therapeutics raised?

NephroDI Therapeutics has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.

Where is NephroDI Therapeutics headquartered?

NephroDI Therapeutics is headquartered in Philadelphia, United States.

What does NephroDI Therapeutics do?

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

What stage is NephroDI Therapeutics at?

NephroDI Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 11, 2024.

MLA

"NephroDI Therapeutics — Funding & Investors." VCBacked, June 11, 2024, https://www.vcbacked.co/company/nephrodi-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). NephroDI Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nephrodi-therapeutics

Wikipedia (cite web)

{{cite web |title=NephroDI Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nephrodi-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 11, 2024.